Dose escalation intensifies and restarts this timeline
Long-term adherence is essential to realizing the full therapeutic potential of GLP-1s, yet behavioral factors (such as reaching personal weight goals or perceived social stigma) and systemic issues (like high out-of-pocket costs and fragmented care) disproportionately affect obesity patients
Bring this information to your WeightCare physician check-ins so they can make informed dosing decisions
Aim This review aims to provide an integrated synthesis that bridges mechanistic evidence (anti-inflammatory, antioxidant) with clinical outcomes (mortality, arrhythmias) for LC supplementation in CAD, while critically appraising inconsistencies across the literature (e.g., heart failure, reinfarction)
Supports heart health and cardiovascular function
You should leave with a plan you can explain in plain language